BlackRock’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

BlackRock’s Portfolio OCEA Stock Details OCEA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-60,499	Closed	-$3.27K	–	5636
2025 Q1	$3.27K	Sell	60,499 -378	-0.6%	-$90	﹤0.01%	5278
2024 Q4	$33.7K	Buy	60,877 +126	+0.2%	+$99	﹤0.01%	5030
2024 Q3	$59.5K	Sell	60,751 -39,129	-39%	-$41.9K	﹤0.01%	4775
2024 Q2	$122K	Sell	99,880 -371,072	-79%	-$633K	﹤0.01%	4655
2024 Q1	$1.78M	Buy	470,952 +184,513	+64%	+$347K	﹤0.01%	4036
2023 Q4	$189K	Sell	286,439 -205,817	-42%	-$282K	﹤0.01%	4654
2023 Q3	$1.92M	Buy	492,256 +57,276	+13%	+$263K	﹤0.01%	4012
2023 Q2	$2.61M	Buy	+434,980	New	+$2.55M	﹤0.01%	3941

Other funds holding OCEA

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Vanguard Personalized Indexing Management Oakland, California $12.2B AUM 47.93% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

SMA

Sage Mountain Advisors Atlanta, Georgia $1.63B AUM 18.97% 1-Year Est. Return

BlackRock's OCEA Position: Q2 2025 in Review

BlackRock sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q2 2025, closing a stake of 60,499 shares — an estimated $3.27K sold.

BlackRock first reported a position in OCEA in Q2 2023 and held it in 8 quarters. The position peaked at $2.61M in Q2 2023. 7 funds tracked by Wall St. Rank hold OCEA as of Q2 2025.

BlackRock reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
BlackRock sold 60,499 Ocean Biomedical, Inc. Common Stock shares in Q2 2025, an estimated $3.27K.
BlackRock first reported a position in Ocean Biomedical, Inc. Common Stock in Q2 2023 and held it in 8 quarters.
BlackRock's Ocean Biomedical, Inc. Common Stock position peaked at $2.61M in Q2 2023.
7 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q2 2025.

Based on BlackRock's 13F filing for Q2 2025, filed 12 Aug 2025.